The Valley Desk

NCT03704077 · Interventional trial

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Overall registry status Withdrawn

Phase 2

Conditions Cancer of the Stomach, Gastric Cancer, Gastroesophageal Junction, Stomach Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov